![]()
|
|
||||||||
J. Biol. Chem., Vol. 283, Issue 31, 21579-21587, August 1, 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1

2
From the
Department of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York, the
Division of Molecular Neurobiology, Department of Basic Medical Sciences, Institute of Medical Science, University of Tokyo, Tokyo, Japan, and the ¶Laboratory for Developmental Neurobiology, Brain Development Research Group, Brain Science Institute, RIKEN, Saitama, Japan
ATP enhances Ca2+ release from inositol (1,4,5)-trisphosphate receptors (InsP3R). However, the three isoforms of InsP3R are reported to respond to ATP with differing sensitivities. Ca2+ release through InsP3R1 is positively regulated at lower ATP concentrations than InsP3R3, and InsP3R2 has been reported to be insensitive to ATP modulation. We have reexamined these differences by studying the effects of ATP on InsP3R2 and InsP3R3 expressed in isolation on a null background in DT40 InsP3R knockout cells. We report that the Ca2+-releasing activity as well as the single channel open probability of InsP3R2 was enhanced by ATP, but only at submaximal InsP3 levels. Further, InsP3R2 was more sensitive to ATP modulation than InsP3R3 under similar experimental conditions. Mutations in the ATPB sites of InsP3R2 and InsP3R3 were generated, and the functional consequences of these mutations were tested. Surprisingly, mutation of the ATPB site in InsP3R3 had no effect on ATP modulation, suggesting an additional locus for the effects of ATP on this isoform. In contrast, ablation of the ATPB site of InsP3R2 eliminated the enhancing effects of ATP. Furthermore, this mutation had profound effects on the patterns of intracellular calcium signals, providing evidence for the physiological significance of ATP binding to InsP3R2.
Received for publication, February 29, 2008 , and in revised form, April 18, 2008.
* This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK054568 and RO1-DE016999 (to D. I. Y.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Supported by NIDCR, National Institutes of Health, Training Grant T32-DE07202.
2 To whom correspondence should be addressed: 601 Elmwood Ave., Box 711, Rochester, NY 14625. Tel.: 585-273-2154; Fax: 585-273-2652; E-mail: David_Yule{at}urmc.rochester.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |